Synopsis of recent research by authors named "Zhujun Xu"
- Zhujun Xu's recent research spans diverse fields, including orthopedic surgery, oncology, pharmacology, and education, addressing significant clinical and theoretical issues such as deep vein thrombosis (DVT) prevention after hip replacement surgery, the role of long noncoding RNAs in cancer progression, and the potential of CRISPR technology in overcoming drug resistance in cancer treatment.
- Xu's findings on fondaparinux sodium versus low-molecular-weight heparin reveal important insights into optimal DVT prevention strategies post-total hip arthroplasty, while studies on long intergenic non-protein coding RNA 115 (Linc00115) suggest its significant oncogenic potential across various malignancies, linking RNA expression levels to clinical outcomes.
- Additionally, research on the influence of social networks in technology-enhanced classrooms highlights contemporary educational dynamics, underscoring the growing utilization of social media for informal learning, while work on mutant TP53 and osteosarcoma explores the molecular mechanisms underlying tumor heterogeneity and drug resistance.
